Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726284 · ClinicalTrials.gov registry record
Spine Patient Outcomes Registry for Biomet/EBI (Electro-Biology, Inc)
A clinical trial of Degenerative Disc Disease and Spinal Stenosis, sponsored by Zimmer Biomet.
- Completed
- Registry status
- 651
- Enrollment target
- 5
- Study locations
NCT00726284: Completed study of Degenerative Disc Disease and Spinal Stenosis, sponsored by Zimmer Biomet.
NCT00726284 is a study of Degenerative Disc Disease and Spinal Stenosis that has completed, run by Zimmer Biomet. The registered enrollment target is 651 participants, above the 153-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (325% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00726284, a study of Degenerative Disc Disease and Spinal Stenosis, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- 651 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this patient registry is to prospectively collect data on patients who are having spinal surgery with EBI and Interpore Cross Spine Products.
Primary Outcome
The primary outcome measure for this trial will be the percentage of successful fusions achieved.
Conditions Studied
Study Locations (5)
Arkansas
- Neurological Surgery Associates - Little Rock
Florida
- Florida Orthopedics Association - Orange City
Ohio
- CNS Healthcare - Akron
Oklahoma
- Oklahoma Spine and Brain - Tulsa
Pennsylvania
- Pottstown Memorial Medical Center - Pottstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 651 participants |
| Start Date | 2004-04 |
| Est. Completion | 2007-12-06 |
What the finished NCT00726284 record still lists
NCT00726284 is an observational study that tracks outcomes without assigning an intervention. The registered 651 participants enrollment target is mid-sized for trials with a published cap, above the 153-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (325% higher).
The record links to 2 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00726284 lists 5 locations in 5 states (Arkansas, Florida, Ohio).
Frequently Asked Questions
What is clinical trial NCT00726284 about?
NCT00726284 is a clinical study titled "Spine Patient Outcomes Registry for Biomet/EBI (Electro-Biology, Inc)". The purpose of this patient registry is to prospectively collect data on patients who are having spinal surgery with EBI and Interpore Cross Spine Products.
What is the current status of trial NCT00726284?
This trial is currently completed. The enrollment target is 651 participants. The study started on 2004-04. Estimated completion is 2007-12-06.
What conditions does trial NCT00726284 study?
This clinical trial studies the following conditions: Degenerative Disc Disease, Spinal Stenosis.
Who is sponsoring clinical trial NCT00726284?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00726284 being conducted?
This trial has 5 study locations across Arkansas, Florida, Ohio, Oklahoma, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00726284's enrollment target sits among peer trials
651 2nd of 42 the highest of 42 other Degenerative Disc Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Degenerative Disc Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
OssDsign® Spine Registry Study ("Propel")
RECRUITING
-
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
RECRUITING · Phase 3
-
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
RECRUITING · Phase 1
-
Investigation of DEXA-C Anterior Cervical Interbody System
RECRUITING · NA
-
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
RECRUITING · NA
-
Trial for Treating Painful Degenerative Disc Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06287346 · 652 participants
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
- NCT02934477 · 650 participants
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
- NCT04579120 · 650 participants
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
- NCT04875702 · 650 participants · Phase 4
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia